Related Experiment Videos
Expression of the FMR1 gene
1Department of Biological Chemistry, University of California, Davis, School of Medicine, Davis CA, USA. ftassone@ucdavis.edu
Cytogenetic and Genome Research
|October 4, 2003
Summary
Fragile X syndrome involves FMR1 gene repeat expansions. Lowered FMRP levels, not reduced transcription, cause the fragile X phenotype due to impaired translation.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- Fragile X syndrome is a trinucleotide repeat disorder.
- It is caused by expansion of the (CGG)n element in the FMR1 gene.
- Full mutations lead to hypermethylation and lack of FMR1 protein (FMRP).
Purpose of the Study:
- To investigate FMR1 gene expression and FMRP levels in various fragile X genotypes.
- To understand the molecular mechanisms underlying the fragile X phenotype spectrum.
- To clarify the relationship between FMR1 mRNA levels, FMRP production, and clinical presentation.
Main Methods:
- Analysis of FMR1 gene expression in cells with premutation and full mutation alleles.
- Quantification of FMR1 mRNA and FMRP levels across different fragile X categories.
- Assessment of FMR1 gene methylation status.
Main Results:
- Elevated FMR1 mRNA levels were observed in premutation and partially methylated full mutation alleles.
- FMRP deficit is present in all fragile X categories, including premutation carriers.
- Lowered FMRP levels, even without gene silencing, result from reduced translation efficiency.
Conclusions:
- FMR1 gene expression is complex, involving elevated mRNA levels in premutations.
- FMRP deficits are consistently observed, irrespective of methylation-coupled silencing.
- Reduced translation efficiency, not transcriptional inactivity, underlies FMRP deficiency in fragile X syndrome.